In terms of liver function, the prototype patients showed significantly higher rates of abnormalities in PA (81.5% vs. 16.6%), ALB (41.4% vs. 0.5%), TB (33.8% vs. 6.5%), ALT (50.3% vs. 11.1%), AST (37.6% vs. 9.5%), GGT (38.9% vs. 15.1%), ALP (8.3% vs. 1.5%), LDH (45.9% vs. 1.5%) and CHE (14.6% vs. 0.0%) than the Omicron BA.5.2 patients (P < 0.05) (Table 2). The gene discussed is GPT; the disease is tuberculosis.